Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Commitment to Quality
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Commitment to Quality
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Press Releases
Biosimilars Council Press Releases
Press Releases
Press Releases
August 13, 2021
AAM
AAM Statement on President’s Build Back Better Plan
Press Releases
August 10, 2021
AAM
Joe Russo Joins AAM as Senior Director, Federal Government Affairs
Press Releases
July 28, 2021
AAM
Joanne Duncan Joins AAM as Chief Operating Officer
Press Releases
July 20, 2021
AAM
AAM Releases New Report: New Generics Are Less Available in Medicare Than Commercial Plans
Press Releases
July 1, 2021
AAM
AAM Statement on the Anniversary of USMCA
Press Releases
June 30, 2021
AAM
AAM Statement on Gov. Mills’ Veto of LD 1117
Press Releases
June 18, 2021
AAM
AAM Statement on Governor Mill’s Consideration of LD 1117
Press Releases
June 17, 2021
AAM
AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas
Press Releases
June 16, 2021
AAM
AAM Statement on Maine LD 1117
Press Releases
June 8, 2021
AAM
AAM Statement on Biden-Harris Administration’s 100-Day Supply Chain Review
Press Releases
May 26, 2021
AAM
Black Women’s Health Imperative Named AAM’s 2021 “Champion of Access”
Press Releases
May 24, 2021
AAM
Steven Selde Joins AAM’s Biosimilars Council as Director
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Commitment to Quality
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH